Epidemiology and Historical Drug Use Patterns

  • Scott E. HadlandEmail author


The use of most substances among adolescents in the United States has fallen in recent years. However, important exceptions to this general trend include the rise in marijuana use, including daily use, among adolescents, and the emergence of e-cigarettes and vaping. The purpose of this chapter is to provide an overview of recent and historical trends in adolescent substance use. This information provides the basis for subsequent chapters to review screening and management of adolescent substance use and substance use disorders. This chapter begins with an overview of adolescent substance use epidemiology, followed by a brief review of the national surveys used in the United States to track substance use in the general adolescent population. The text then reviews recent and historical trends in use of alcohol, marijuana, nicotine, opioids, and other substances to lay the groundwork for clinicians to acquire more specific knowledge and skills to address adolescent substance use in the chapters that follow.


Adolescents Marijuana Alcohol Nicotine Opioids Substance use disorders Epidemiology 


  1. 1.
    Jamal A, Gentzke A, Hu SS, Cullen KA, Apelberg BJ, Homa DM, et al. Tobacco use among middle and high school students – United States, 2011–2016. MMWR Morb Mortal Wkly Rep. 2017;66(23):597–603.CrossRefGoogle Scholar
  2. 2.
    Jang JB, Patrick ME, Keyes KM, Hamilton AD, Schulenberg JE. Frequent binge drinking among US adolescents, 1991 to 2015. Pediatrics. 2017;139(6):e20164023.CrossRefGoogle Scholar
  3. 3.
    Welsh JW, Knight JR, Hadland SE. Adolescent frequent heavy drinking from 1991–2015. Pediatrics. 2017;139(6):e20170932.CrossRefGoogle Scholar
  4. 4.
    Gonzales K, Roeber J, Kanny D, Tran A, Saiki C, Johnson H, et al. Alcohol-attributable deaths and years of potential life lost – 11 States, 2006–2010. MMWR Morb Mortal Wkly Rep. 2014 Mar;63(10):213–6.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Johnston LD, Miech RA, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Monitoring the future national survey results on drug use: 1975–2017: overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan; 2018.Google Scholar
  6. 6.
    Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133–9.CrossRefGoogle Scholar
  7. 7.
    Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(8):788–97.CrossRefGoogle Scholar
  8. 8.
    Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. 2017;171(8):747–55.CrossRefGoogle Scholar
  9. 9.
    Curtin SC, Tejada-Vera B, Warner M. Drug overdose deaths among adolescents aged 15–19 in the United States: 1999–2015. NCHS Data Brief, no 282. Atlanta; 2017.Google Scholar
  10. 10.
    Gaither JR, Leventhal JM, Ryan SA, Camenga DR. National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatr. 2016;170(12):1195–201.CrossRefGoogle Scholar
  11. 11.
    Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2003–2013. Rockville: National Admissions to Substance Abuse Treatment Services; 2015.Google Scholar
  12. 12.
    Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017.Google Scholar
  13. 13.
    Kann L, McManus T, Harris WA, Shanklin SL, Flint KH, Hawkins J, et al. Youth risk behavior surveillance – United States. MMWR Surveill Summ. 2015;65(6):1–174.CrossRefGoogle Scholar
  14. 14.
    Corliss HL, Goodenow CS, Nichols L, Austin SB. High burden of homelessness among sexual-minority adolescents: findings from a representative Massachusetts high school sample. Am J Public Health. 2011;101(9):1683–9.CrossRefGoogle Scholar
  15. 15.
    Statistics Canada. Canadian Tobacco, Alcohol and Drugs Survey (CTADS): 2015 summary [Internet]. Ottawa: Health Canada; 2017. Accessed 10 Apr 2018.
  16. 16.
    National Health Service. Smoking, drinking and drug use among young people in England – 2016 [Internet]. Leeds: NHS Digital; Accessed 10 Apr 2018.
  17. 17.
    US Department of Health and Human Services and US Department of Agriculture. 2015–2020 dietary guidelines for Americans. 8th ed. Washington, DC: US Department of Health and Human Services and US Department of Agriculture; 2015.Google Scholar
  18. 18.
    Heron M. Deaths: leading causes for 2015. Natl Vital Stat Rep. 2017;66(5):1–76.PubMedGoogle Scholar
  19. 19.
    Centers for Disease Control and Prevention. Alcohol-attributable deaths and years of potential life lost among American Indians and Alaska Natives – United States, 2001–2005. MMWR Morb Mortal Wkly Rep. 2008;57(34):938–41.Google Scholar
  20. 20.
    Hadland SE, Xuan Z, Sarda V, Blanchette J, Swahn MH, Heeren TC, et al. Alcohol policies and alcohol-related motor vehicle crash fatalities among young people in the US. Pediatrics. 2017;139(3):e20163037.CrossRefGoogle Scholar
  21. 21.
    Buchmann AF, Schmid B, Blomeyer D, Becker K, Treutlein J, Zimmermann US, et al. Impact of age at first drink on vulnerability to alcohol-related problems: testing the marker hypothesis in a prospective study of young adults. J Psychiatr Res. 2009;43(15):1205–12.CrossRefGoogle Scholar
  22. 22.
    National Conference of State Legislatures. Marijuana Overview [Internet]. Washington, DC: National Conference of State Legislatures; 2017. Accessed 7 May 2018.
  23. 23.
    Cerdá M, Wall M, Feng T, Keyes KM, Sarvet A, Schulenberg J, et al. Association of state recreational marijuana laws with adolescent marijuana use. JAMA Pediatr. 2017;171(2):142–9.CrossRefGoogle Scholar
  24. 24.
    Sarvet AL, Wall MM, Fink DS, Greene E, Le A, Boustead AE, et al. Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis. Addiction. 2018;113(6):1003–16.CrossRefGoogle Scholar
  25. 25.
    Mehmedic Z, Chandra S, Slade D, Denham H, Foster S, Patel AS, et al. Potency trends of Delta9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci. 2010;55(5):1209–17.CrossRefGoogle Scholar
  26. 26.
    Hadland SE, Harris SK. Youth marijuana use: state of the science for the practicing clinician. Curr Opin Pediatr. 2014;26(4):420.CrossRefGoogle Scholar
  27. 27.
    Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109(40):E2657–64.CrossRefGoogle Scholar
  28. 28.
    Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319–28.CrossRefGoogle Scholar
  29. 29.
    Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344:e536.CrossRefGoogle Scholar
  30. 30.
    Demissie Z, Everett Jones S, Clayton HB, King BA. Adolescent risk behaviors and use of electronic vapor products and cigarettes. Pediatrics. 2017;139(2):e20162921.CrossRefGoogle Scholar
  31. 31.
    Pankow JF, Kim K, McWhirter KJ, Luo W, Escobedo JO, Strongin RM, et al. Benzene formation in electronic cigarettes. PLoS One. 2017;12(3):e0173055.CrossRefGoogle Scholar
  32. 32.
    Committee on Substance Use and Prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161211.CrossRefGoogle Scholar
  33. 33.
    Gladden RM, Martinez P, Seth P. Fentanyl law enforcement submissions and increases in synthetic opioid–involved overdose deaths — 27 states, 2013–2014. MMWR Morb Mortal Wkly Rep. 2016;65(33):837–43.CrossRefGoogle Scholar
  34. 34.
    Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893.CrossRefGoogle Scholar
  35. 35.
    Miech RA, Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Monitoring the future national survey results on drug use, 1975–2016: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, The University of Michigan; 2017. p. 229–31.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Grayken Center for Addiction/Department of PediatricsBoston Medical Center, Boston University School of MedicineBostonUSA
  2. 2.Division of General Pediatrics, Department of PediatricsBoston University School of MedicineBostonUSA

Personalised recommendations